The $25 million equity line that Abattis secured with Dutchess Opportunity Fund certainly doesn’t appear to be a hand out from some clueless venture capitalist gold diggers.
Dutchess Capital (Boston, MA) has been thoroughly studying the cannabis market, and some of their publicly available research confirms that they take a scientific approach to identifying potential future marvels in this sector.
Weighing risks versus rewards can be a challenging task in this market, but Dutchess Capital provides a very enlightening summary of their previous research and ultimate decision to invest in American Cannabis Company (AMMJ). I’d invite all Abattis investors to carefully read this:http://media.wix.com/ugd/399f3b_e33f66c9563a442c819f526d89a4dc99.pdf
You’ll find a AMMJ business model that is strikingly similar to some of the various components of Mike Withrow and Abattis’ GDERS model. This appears to be what Dutchess Capital looks for. Companies with existing collections of diversified products and services is still grabbing other investors’ attention.